Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug-induced liver disease.

J H Lewis1, H J Zimmerman

  • 1Division of Gastroenterology, Georgetown University School of Medicine and Hospital, Washington, DC.

The Medical Clinics of North America
|July 1, 1989
PubMed
Summary

Drug-induced liver disease is significant in the elderly, often occurring unexpectedly at therapeutic doses. Susceptibility factors are diverse and explored in this review.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Encephalomyeloradiculitis (Guillain-Barré syndrome) as a complication of infectious hepatitis.

Annals of internal medicine·2010
Same author

Infectious hepatitis; clinical and laboratory features of 295 cases.

The American journal of the medical sciences·2010
Same author

Drug- and chemical-induced cholestasis.

Clinics in liver disease·2001
Same author

Drug-induced liver disease.

Clinics in liver disease·2001
Same author

Management of drug-induced liver disease.

Current gastroenterology reports·2001
Same author

Massive hemorrhage complicating percutaneous endoscopic gastrostomy: treatment by means of transcatheter embolization of the right and left gastroepiploic arteries.

Journal of vascular and interventional radiology : JVIR·1999

Area of Science:

  • Hepatology
  • Clinical Pharmacology
  • Toxicology

Background:

  • Drug-induced liver disease (DILD) is a critical concern, particularly in elderly populations.
  • Most DILD cases manifest as idiosyncratic reactions, even at standard therapeutic drug dosages.
  • Understanding patient susceptibility is key to managing DILD risks.

Purpose of the Study:

  • To highlight the significance of DILD in specific patient cohorts, especially the elderly.
  • To review the common occurrence of unexpected DILD reactions.
  • To discuss the various factors influencing an individual's susceptibility to DILD.

Main Methods:

  • Review of existing literature on drug-induced liver disease.
  • Analysis of case reports and epidemiological data concerning DILD.
  • Discussion of pharmacological and patient-related factors contributing to DILD.

Main Results:

  • Elderly patients represent a vulnerable group for DILD.
  • Unexpected adverse drug reactions are a primary cause of DILD.
  • A complex interplay of factors determines susceptibility to liver injury from medications.

Conclusions:

  • DILD poses a significant clinical challenge, especially in geriatric patients.
  • Proactive identification of risk factors is essential for preventing DILD.
  • Further research into susceptibility mechanisms can improve patient outcomes and drug safety.

Related Experiment Videos